NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to assess the impact of CoQ10 and GPI 1485 on the progression of
Parkinson's disease, in order to determine whether it is reasonable to proceed with further
study of either of these agents.
Phase:
Phase 2
Details
Lead Sponsor:
University of Rochester
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)